Sernova Corp. | WebDisclosure

Basculer en Français

8295	Companies
114809	Keywords
55260	Articles
62422	Press releases

Home
Companies
Sernova Corp.

BRIEF

published on 09/27/2024 at 12:47, 1 month 23 days ago

Sernova Corp: First Berlin Equity Research Maintains Buy Rating

BUY Rating Sernova Corp Clinical Trial Type 1 Diabetes Cell Pouch
BRIEF

published on 09/27/2024 at 12:47, 1 month 23 days ago

Sernova Corp : First Berlin Equity Research maintient sa note d'achat

Sernova Corp Essai Clinique Acheter Une Note Diabète De Type 1 Pochette Pour Cellule
PRESS RELEASE

published on 09/27/2024 at 12:42, 1 month 23 days ago

Original-Research: Sernova Corp (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms Buy rating for Sernova Corp (ISIN: CA81732W1041) with updated price target of CAD1.90 following positive results in treating type 1 diabetes

First Berlin Equity Research BUY Rating Sernova Corp Type 1 Diabetes CAD1.90
PRESS RELEASE

published on 02/06/2024 at 15:02, 9 months 14 days ago

Original-Research: Sernova Corp (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research has reiterated its BUY rating and CAD 3.80 price target for Sernova Corp (ISIN: CA81732W1041) based on the company's financial statement release and business update for FY 22/23. Sernova's achievements in diabetes treatment and potential partnering deal are anticipated to drive stock performance

First Berlin Equity Research Sernova Corp FY 22/23 Diabetes Treatment Partnering Deal
PRESS RELEASE

published on 10/19/2023 at 15:57, 1 year 1 month ago

Original-Research: Sernova Corp (von First Berlin Equity Research GmbH): BUY
PRESS RELEASE

published on 09/14/2023 at 22:06, 1 year 2 months ago

Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22
PRESS RELEASE

published on 09/13/2023 at 13:01, 1 year 2 months ago

Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update
PRESS RELEASE

published on 05/03/2023 at 13:01, 1 year 6 months ago

Sernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell Applications
PRESS RELEASE

published on 04/10/2023 at 13:05, 1 year 7 months ago

Sernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the Med
PRESS RELEASE

published on 03/22/2023 at 12:04, 1 year 7 months ago

Sernova: Abstract on First Cohort of its Phase 1/2 Study Involving Islet Transplantation into Cell Pouch Selected for Oral Podium Presentation at American Diabetes Association 83rd Scientific Sessions

Accesswire

Published on 11/21/2024 at 09:00, 41 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 6 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 16 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 41 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 41 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:01, 40 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 41 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 41 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 26 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 08:09, 1 hour 31 minutes ago

KAP HOLDS ITS GROUND IN A DIFFICULT INDUSTRY ENVIRONMENT IN THE FIRST NINE MONTHS OF 2024

Les Echos

Published on 11/21/2024 at 06:58, 2 hours 43 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 43 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 43 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 33 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 21 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE